Chengdu Kanghong Biotech Co., Ltd.
Chengdu Kanghong Biotech Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-In-Human Study of KHN922 for Injection | Advanced Solid Tumors Cancer | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-09 | NCT07514975 | |
| First-In-Human Study in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2025-04-03 | NCT06885645 |